Chemycal has been acquired by 3E
Learn MoreChemycal has been acquired by 3E
Learn More
Discover how Chemycal PRO helps you boosting your regulatory monitoring:
For many COVID-19 patients battling for their lives in the ICU, a runaway immune system response -- known as a "cytokine storm" -- is their primary foe.
Doctors have few tools to help tame this hyperinflammatory condition, but early research is suggesting that nanotechnology might safely deliver drugs to affected tissues, quieting the storm.
CONTINUE READING ON www.upi.com
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions
